Recognizing Advancements During Psoriasis Awareness Month

The start of August also marks Psoriasis Awareness Month, and this issue of Dermatology Times reflects the pace of innovation shaping care for the estimated 8 million Americans living with the disease. Our cover story, from Shannon Trotter, DO, and a student coauthor, reviews the growing role of peptides in dermatology. The piece centers on icotrokinra (Icotyde; Johnson & Johnson), an oral peptide targeting the IL-23 pathway approved for moderate to severe plaque psoriasis in adults and adolescents 12 years and older, and what its development could mean for patients seeking options beyond injectable biologics.

Other notable mentions in this issue include Shanna Miranti, MPAS, PA-C, who examines the hormonal drivers of acne, with particular attention to the intersection of infertility and skin health. It is a reminder that dermatologic care often intersects with broader systemic and reproductive health concerns.

For advanced practice providers looking to expand their scope, Shawna Jones, PA-C, offers a practical road map for starting or transitioning into aesthetics. Her guidance covers training, credentialing, and building confidence in a fast-growing area of practice.

Finally, Darrell Rigel, MD, breaks down sunscreen safety and ingredient science, with a close look at bemotrizinol, the newest UV filter approved for use in the United States. His analysis offers timely context as patients ask more questions about sun protection heading into the final weeks of summer.

As always, Dermatology Times delivers the most up-to-date clinical content, featuring innovative studies, FDA approvals, exclusive interviews, and expert perspectives. Stay informed with the latest data: Subscribe to Dermatology Times’ e-newsletters and follow us on LinkedIn, Instagram, Facebook, X, and YouTube.